{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "2414765",
  "DateCompleted": {
    "Year": "1985",
    "Month": "11",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "07",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0032-5481",
      "JournalIssue": {
        "Volume": "78",
        "Issue": "6",
        "PubDate": {
          "Year": "1985",
          "Month": "Nov",
          "Day": "01"
        }
      },
      "Title": "Postgraduate medicine",
      "ISOAbbreviation": "Postgrad Med"
    },
    "ArticleTitle": "Pulmonary hypertension. A common but often overlooked condition.",
    "Pagination": {
      "StartPage": "109",
      "EndPage": "114",
      "MedlinePgn": "109-14"
    },
    "Abstract": {
      "AbstractText": [
        "Pulmonary hypertension accompanies many primary disorders and produces common symptoms. However, measurement of pulmonary blood pressure is not routine, and as a result, symptoms are often overlooked. Pulmonary hypertension may lead to cor pulmonale, which has an unfavorable prognosis. Drug treatment for pulmonary hypertension and cor pulmonale may improve prognosis and prolong life. In cases of irreversible primary disease, therapy is palliative. Vasodilator therapy appears to benefit certain patients with primary pulmonary hypertension."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Goldstein",
        "ForeName": "R A",
        "Initials": "RA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Postgrad Med",
    "NlmUniqueID": "0401147",
    "ISSNLinking": "0032-5481"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Diuretics"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Vasodilator Agents"
    },
    {
      "RegistryNumber": "S88TT14065",
      "NameOfSubstance": "Oxygen"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Constriction, Pathologic"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Diuretics"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Hypertension, Pulmonary"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Oxygen"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Palliative Care"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pulmonary Artery"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pulmonary Circulation"
    },
    {
      "QualifierName": [
        "diagnostic imaging",
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Pulmonary Heart Disease"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Radionuclide Imaging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Regional Blood Flow"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Vascular Diseases"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Vasodilator Agents"
    }
  ]
}